Loading... Please wait...

2/2011 Librede receives Phase II SBIR funding from the NIH

Posted

Librede has received a Phase II SBIR grant from the National Institute of Health, “Development of a disposable cell-free ion channel measurement platform for hERG screening,” to continue the development of their platform.  

Press Release